Mar 14 |
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
|
Mar 12 |
Acadia (ACAD) Down as Schizophrenia Study on Nuplazid Fails
|
Mar 12 |
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
|
Mar 11 |
FibroGen appoints Deyaa Adib as Chief Medical Officer
|
Mar 11 |
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
|
Mar 11 |
Novo Nordisk's (NVO) Wegovy Gets FDA Nod to Reduce Heart Risk
|
Feb 29 |
FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcript
|
Feb 29 |
US$1.25: That's What Analysts Think FibroGen, Inc. (NASDAQ:FGEN) Is Worth After Its Latest Results
|
Feb 28 |
FibroGen Full Year 2023 Earnings: Misses Expectations
|
Feb 27 |
Q4 2023 FibroGen Inc Earnings Call
|